Skip to Content
Last Updated: 04/25/2012

CTEP Online Resources for Industry Collaborators

CTEP offers a unique combination of resources and expertise to assist industry collaborators in clinical development of new therapeutic agents and the ability to evaluate investigational agents in a wide variety of tumor types and disease settings. This section of the CTEP website provides information regarding the process for co-developing an investigational anticancer agent with NCI, for example:

About the
Associate Director

Jeffrey S. Abrams, M.D. Jeffrey S. Abrams, M.D., has led the Cancer Therapy Evaluation Program (CTEP) since June 2007.  Dr. Abrams came to CTEP in 1993 when he joined as a clinical research scientist to oversee the breast cancer treatment trials portfolio and participate in clinical trials at the NIH Clinical Center and the National Naval Medical Center. More…

For More Details
About CTEP